Contrast Media: Types, Administration, and Patient Monitoring

What Is Contrast Media?

Contrast media (also called contrast agents) are substances introduced into the body to improve the visibility of internal structures on radiographic images. Because soft tissues, fluids, and hollow organs often appear similar in density on plain radiographs, contrast agents make those structures stand out. Understanding the types of contrast media, their risks, and your responsibilities before and after administration is a core patient-safety competency for every radiographer.

Iodinated Contrast Agents

Iodinated contrast agents are water-soluble compounds containing iodine, which strongly absorbs X-rays. They are used for procedures such as intravenous urography, CT with contrast, myelography, and arthrography. There are two main categories:

Ionic (high-osmolality) agents dissociate into charged particles in solution. They have a higher osmolality than blood plasma, which contributes to a greater rate of adverse reactions including pain, heat sensation, nausea, and cardiovascular stress. Their use has largely been replaced by nonionic agents for most procedures.

Nonionic (low-osmolality) agents do not dissociate into charged particles. They are better tolerated, carry a lower risk of adverse reactions, and are now the standard of care for most iodinated contrast procedures. Examples of nonionic agents include iohexol, iopamidol, and iodixanol (iso-osmolar).

Key Contraindications for Iodinated Agents

• Prior severe allergic-like reaction to iodinated contrast is the most significant contraindication. A prior mild or moderate reaction requires physician evaluation; premedication protocols (typically corticosteroids and antihistamines) may be ordered.
• Renal insufficiency: Iodinated contrast can cause contrast-induced nephropathy. Current creatinine and estimated glomerular filtration rate (eGFR) values must be reviewed according to facility protocol before IV contrast is given.
• Metformin: This oral diabetes medication is held before or after contrast administration according to physician order and facility protocol, because impaired renal clearance after contrast can theoretically increase the risk of metformin-associated lactic acidosis. The specific timing and criteria for holding metformin are determined by the ordering physician and facility policy.
• Hyperthyroidism / thyroid conditions: Iodine load can affect thyroid function; physician awareness is required.
• Multiple myeloma and other conditions affecting renal function increase risk and require physician clearance.

Barium Sulfate Preparations

Barium sulfate is an inert, insoluble compound used exclusively for gastrointestinal (GI) studies such as upper GI series, small bowel follow-through, and barium enema. Because it is not absorbed by the body, it is generally well tolerated.

Key contraindications for barium:

• Suspected perforation of the GI tract: Barium leaking into the peritoneum or mediastinum causes severe peritonitis and can be fatal. If perforation is suspected, a water-soluble iodinated agent is substituted.
• Pre-surgical patients: Retained barium can complicate surgery and anastomoses.
• Aspiration risk: In patients at high risk for aspiration, a water-soluble agent may be preferred because aspirated barium can cause pneumonitis.

Barium preparations come in various concentrations (expressed as weight-to-volume percentages) and formulations (liquid, paste, tablet) chosen based on the study type.

Gadolinium-Based Contrast Agents

Gadolinium-based contrast agents (GBCAs) are primarily used in MRI. Although they are not iodine-based, radiographers working in facilities with MRI should be aware of them.

Key concern — Nephrogenic Systemic Fibrosis (NSF): In patients with severe renal impairment, certain GBCAs have been associated with NSF, a serious fibrosing condition. Renal function screening is therefore required before GBCA administration. The FDA has issued guidance on GBCA groupings and risk stratification.

Pre-Procedure Screening Requirements

Before any contrast study, the radiographer's role in screening is critical:

1. Review the patient's medical history: allergies (especially prior contrast reactions), renal disease, diabetes, thyroid disease, and current medications (particularly metformin, NSAIDs, and nephrotoxic drugs).

2. Verify lab values: Obtain or confirm creatinine/eGFR results per facility protocol. Many facilities define a minimum eGFR threshold for contrast administration.

3. Confirm the physician's order includes contrast and that the indication is appropriate.

4. Obtain informed consent: The ordering physician or a licensed practitioner obtains informed consent; the radiographer confirms it is documented before proceeding.

5. Escalate appropriately: If a patient has a known severe prior reaction, impaired renal function outside acceptable parameters, or is taking a medication requiring physician guidance, stop and obtain radiologist or physician clearance before proceeding. This is a non-negotiable patient-safety step within your scope.

Routes of Administration

• Intravenous (IV): Most common for iodinated agents in CT and urography; requires a patent, appropriately sized IV catheter.
• Oral: Barium or dilute iodinated contrast for GI studies.
• Rectal: Barium enema procedures.
• Intrathecal: Nonionic iodinated contrast only, for myelography; performed by a physician.
• Intra-articular: For arthrography; performed by a physician.

Note: In most states and facilities, IV contrast injection is performed or directly supervised by a physician or authorized licensed practitioner. The radiographer prepares, labels, and documents contrast but must know the scope of practice in their state.

Post-Procedure Monitoring

After contrast administration, the radiographer monitors the patient for adverse reactions:

• Mild reactions: Warmth, flushing, nausea, urticaria (hives). Monitor, document, notify radiologist.
• Moderate reactions: Severe urticaria, bronchospasm, mild hypotension. Notify radiologist immediately; be prepared to assist with treatment.
• Severe (anaphylactoid) reactions: Cardiovascular collapse, laryngeal edema, loss of consciousness. Activate emergency response immediately.

All reaction emergency equipment (epinephrine, oxygen, crash cart) must be accessible in any room where IV contrast is used. Document all reactions and actions taken per facility policy.

Scope of Practice Reminder

The radiographer screens, prepares, labels, and documents contrast; monitors patients; and escalates concerns. Prescribing contrast, performing intrathecal or intra-articular injection, and independent clinical decision-making about dosing are outside the radiographer's scope.